366 related articles for article (PubMed ID: 32892355)
21. Cognitive Profile and Markers of Alzheimer Disease-Type Pathology in Patients With Lewy Body Dementias.
Howard E; Irwin DJ; Rascovsky K; Nevler N; Shellikeri S; Tropea TF; Spindler M; Deik A; Chen-Plotkin A; Siderowf A; Dahodwala N; Weintraub D; Shaw LM; Trojanowski JQ; Vaishnavi SN; Wolk DA; Mechanic-Hamilton D; Morley JF; Duda JE; Grossman M; Cousins KAQ
Neurology; 2021 Apr; 96(14):e1855-e1864. PubMed ID: 33593865
[TBL] [Abstract][Full Text] [Related]
22. Effect of topographical distribution of α-synuclein pathology on TDP-43 accumulation in Lewy body disease.
Yokota O; Davidson Y; Arai T; Hasegawa M; Akiyama H; Ishizu H; Terada S; Sikkink S; Pickering-Brown S; Mann DM
Acta Neuropathol; 2010 Dec; 120(6):789-801. PubMed ID: 20669025
[TBL] [Abstract][Full Text] [Related]
23. CSF Synaptic Biomarkers in AT(N)-Based Subgroups of Lewy Body Disease.
Barba L; Abu-Rumeileh S; Halbgebauer S; Bellomo G; Paolini Paoletti F; Gaetani L; Oeckl P; Steinacker P; Massa F; Parnetti L; Otto M
Neurology; 2023 Jul; 101(1):e50-e62. PubMed ID: 37188538
[TBL] [Abstract][Full Text] [Related]
24. Relationship between hippocampal atrophy and neuropathology markers: a 7T MRI validation study of the EADC-ADNI Harmonized Hippocampal Segmentation Protocol.
Apostolova LG; Zarow C; Biado K; Hurtz S; Boccardi M; Somme J; Honarpisheh H; Blanken AE; Brook J; Tung S; Lo D; Ng D; Alger JR; Vinters HV; Bocchetta M; Duvernoy H; Jack CR; Frisoni GB;
Alzheimers Dement; 2015 Feb; 11(2):139-50. PubMed ID: 25620800
[TBL] [Abstract][Full Text] [Related]
25. Downstream effects of polypathology on neurodegeneration of medial temporal lobe subregions.
Wisse LEM; Ravikumar S; Ittyerah R; Lim S; Lane J; Bedard ML; Xie L; Das SR; Schuck T; Grossman M; Lee EB; Tisdall MD; Prabhakaran K; Detre JA; Mizsei G; Trojanowski JQ; Artacho-Pérula E; de Iñiguez de Onzono Martin MM; M Arroyo-Jiménez M; Muñoz Lopez M; Molina Romero FJ; P Marcos Rabal M; Cebada Sánchez S; Delgado González JC; de la Rosa Prieto C; Córcoles Parada M; Wolk DA; Irwin DJ; Insausti R; Yushkevich PA
Acta Neuropathol Commun; 2021 Jul; 9(1):128. PubMed ID: 34289895
[TBL] [Abstract][Full Text] [Related]
26. Significant Overlap of α-Synuclein, Amyloid-β, and Phospho-Tau Pathologies in Neuropathological Diagnosis of Lewy-related Pathology: Evidence from China Human Brain Bank.
Cong C; Zhang W; Qian X; Qiu W; Ma C
J Alzheimers Dis; 2021; 80(1):447-458. PubMed ID: 33554920
[TBL] [Abstract][Full Text] [Related]
27. β-Amyloid PET and neuropathology in dementia with Lewy bodies.
Kantarci K; Lowe VJ; Chen Q; Przybelski SA; Lesnick TG; Schwarz CG; Senjem ML; Gunter JL; Jack CR; Graff-Radford J; Jones DT; Knopman DS; Graff-Radford N; Ferman TJ; Parisi JE; Dickson DW; Petersen RC; Boeve BF; Murray ME
Neurology; 2020 Jan; 94(3):e282-e291. PubMed ID: 31862783
[TBL] [Abstract][Full Text] [Related]
28. Amyloid-Beta (Aβ) Plaques Promote Seeding and Spreading of Alpha-Synuclein and Tau in a Mouse Model of Lewy Body Disorders with Aβ Pathology.
Bassil F; Brown HJ; Pattabhiraman S; Iwasyk JE; Maghames CM; Meymand ES; Cox TO; Riddle DM; Zhang B; Trojanowski JQ; Lee VM
Neuron; 2020 Jan; 105(2):260-275.e6. PubMed ID: 31759806
[TBL] [Abstract][Full Text] [Related]
29. The molecular spectrum of amyloid-beta (Aβ) in neurodegenerative diseases beyond Alzheimer's disease.
Ichimata S; Yoshida K; Li J; Rogaeva E; Lang AE; Kovacs GG
Brain Pathol; 2024 Jan; 34(1):e13210. PubMed ID: 37652560
[TBL] [Abstract][Full Text] [Related]
30. Hippocampal CA2 Lewy pathology is associated with cholinergic degeneration in Parkinson's disease with cognitive decline.
Liu AKL; Chau TW; Lim EJ; Ahmed I; Chang RC; Kalaitzakis ME; Graeber MB; Gentleman SM; Pearce RKB
Acta Neuropathol Commun; 2019 Apr; 7(1):61. PubMed ID: 31023342
[TBL] [Abstract][Full Text] [Related]
31. Disease and brain region specific immune response profiles in neurodegenerative diseases with pure and mixed protein pathologies.
Bathe T; Hery GP; Villareal JAB; Phillips JL; Cohen EM; Sharma RV; Tsering W; Prokop S
Acta Neuropathol Commun; 2024 Apr; 12(1):54. PubMed ID: 38581050
[TBL] [Abstract][Full Text] [Related]
32. Interaction between Abeta peptide and alpha synuclein: molecular mechanisms in overlapping pathology of Alzheimer's and Parkinson's in dementia with Lewy body disease.
Mandal PK; Pettegrew JW; Masliah E; Hamilton RL; Mandal R
Neurochem Res; 2006 Sep; 31(9):1153-62. PubMed ID: 16947080
[TBL] [Abstract][Full Text] [Related]
33. Hippocampal Reduction of α-Synuclein via RNA Interference Improves Neuropathology in Alzheimer's Disease Mice.
Leitão ADG; Spencer B; Sarsoza F; Ngolab J; Amalraj J; Masliah E; Wu C; Rissman RA
J Alzheimers Dis; 2023; 95(1):349-361. PubMed ID: 37522208
[TBL] [Abstract][Full Text] [Related]
34. Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia.
Chiasserini D; Biscetti L; Eusebi P; Salvadori N; Frattini G; Simoni S; De Roeck N; Tambasco N; Stoops E; Vanderstichele H; Engelborghs S; Mollenhauer B; Calabresi P; Parnetti L
Alzheimers Res Ther; 2017 Jul; 9(1):52. PubMed ID: 28750675
[TBL] [Abstract][Full Text] [Related]
35. ADNC-RS, a clinical-genetic risk score, predicts Alzheimer's pathology in autopsy-confirmed Parkinson's disease and Dementia with Lewy bodies.
Dai DL; Tropea TF; Robinson JL; Suh E; Hurtig H; Weintraub D; Van Deerlin V; Lee EB; Trojanowski JQ; Chen-Plotkin AS
Acta Neuropathol; 2020 Oct; 140(4):449-461. PubMed ID: 32749525
[TBL] [Abstract][Full Text] [Related]
36. Unique α-synuclein pathology within the amygdala in Lewy body dementia: implications for disease initiation and progression.
Sorrentino ZA; Goodwin MS; Riffe CJ; Dhillon JS; Xia Y; Gorion KM; Vijayaraghavan N; McFarland KN; Golbe LI; Yachnis AT; Giasson BI
Acta Neuropathol Commun; 2019 Sep; 7(1):142. PubMed ID: 31477175
[TBL] [Abstract][Full Text] [Related]
37. Relationship of phosphorylated alpha-synuclein and tau accumulation to Abeta deposition in the cerebral cortex of dementia with Lewy bodies.
Obi K; Akiyama H; Kondo H; Shimomura Y; Hasegawa M; Iwatsubo T; Mizuno Y; Mochizuki H
Exp Neurol; 2008 Apr; 210(2):409-20. PubMed ID: 18164295
[TBL] [Abstract][Full Text] [Related]
38. Human amyloid beta and α-synuclein co-expression in neurons impair behavior and recapitulate features for Lewy body dementia in Caenorhabditis elegans.
Huang X; Wang C; Chen L; Zhang T; Leung KL; Wong G
Biochim Biophys Acta Mol Basis Dis; 2021 Oct; 1867(10):166203. PubMed ID: 34146705
[TBL] [Abstract][Full Text] [Related]
39. The relationship between hippocampal amyloid beta burden and spatial distribution of neurofibrillary degeneration.
Walker JM; Goette W; Farrell K; Iida MA; Karlovich E; ; White CL; Crary JF; Richardson TE
Alzheimers Dement; 2023 Jul; 19(7):3158-3170. PubMed ID: 36738450
[TBL] [Abstract][Full Text] [Related]
40. Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis.
Irwin DJ; Grossman M; Weintraub D; Hurtig HI; Duda JE; Xie SX; Lee EB; Van Deerlin VM; Lopez OL; Kofler JK; Nelson PT; Jicha GA; Woltjer R; Quinn JF; Kaye J; Leverenz JB; Tsuang D; Longfellow K; Yearout D; Kukull W; Keene CD; Montine TJ; Zabetian CP; Trojanowski JQ
Lancet Neurol; 2017 Jan; 16(1):55-65. PubMed ID: 27979356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
